(17beta)-17-Hydroxyandrost-4-en-3-one | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

(17beta)-17-Hydroxyandrost-4-en-3-one
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Hubei Gedian Humanwell Pharmaceutical Testosterone

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

(17beta)-17-Hydroxyandrost-4-en-3-one

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 22 USDMF, 8 CEP/COS, 6 EU WC, 43 NDC API, 17 Listed Suppliers, $ API Reference Price

36 API Suppliers
22 USDMF
8 CEP/COS
6 EU WC
43 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

126 FDF Dossiers, 60 FDA Orange Book, 39 Europe, 7 Canada, 7 Australia, 8 South Africa, 5 Listed Dossiers

126 FDF Dossiers
60 FDA Orange Book
39 Europe
7 Canada
7 Australia
8 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION, GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 50MG/5GM PACKET, TABLET, EXTENDED RELEASE;BUCCAL - 30MG, GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION), GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION
GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 50MG/5GM PACKET
TABLET, EXTENDED RELEASE;BUCCAL - 30MG
GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION)
GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 2 DKSH, 1 Jai Radhe Sales, 6 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 BioSpectra, 2 Clariant, 15 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Lubrizol Life Science Health, 14 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 35 Topical, 33 Direct Compression, 30 Controlled & Modified Release, 25 Thickeners and Stabilizers, 21 Disintegrants & Superdisintegrants, 21 Granulation, 19 Lubricants & Glidants, 19 Co-Processed Excipients, 16 Film Formers & Plasticizers, 16 Solubilizers, 13 Parenteral, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents

75 Fillers, Diluents & Binders
44 Coating Systems & Additives
35 Topical
33 Direct Compression
30 Controlled & Modified Release
25 Thickeners and Stabilizers
21 Disintegrants & Superdisintegrants
21 Granulation
19 Lubricants & Glidants
19 Co-Processed Excipients
16 Film Formers & Plasticizers
16 Solubilizers
13 Parenteral
7 Taste Masking
6 Chewable & Orodispersible Aids
6 API Stability Enhancers
6 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
4 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 120 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
120 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 36 Finished Drug Prices, 12 Annual Reports

7 US Medicaid Prescriptions
36 Finished Drug Prices
12 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 8 Health Canada Patents

41 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 EDQM, 1 USP, 6 Others

10 EDQM
1 USP
6 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ API Ref.Price (USD/KG) : 436 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 2TARO PHARMACEUTICALS INC

02 1ACERUS BIOPHARMA INC

03 3BGP PHARMA ULC

04 1ENDO OPERATIONS LTD.

filter Active Ingredients Reset all filters

7 All

01 7TESTOSTERONE

filter Dosage Form Reset all filters

7 All

01 7GEL

filter Brand Name Reset all filters

7 All

01 3ANDROGEL

02 1NATESTO

03 2TARO-TESTOSTERONE GEL

04 1TESTIM 1%

Aspen Testosterone

List of Suppliers

Product Main Page

01

TARO PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : TARO-TESTOSTERONE GEL

Dosage Form : GEL

Dosage Strength : 1%

Packaging : 2.5GX30

Approval Date :

Application Number : 2463792

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TARO PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : TARO-TESTOSTERONE GEL

Dosage Form : GEL

Dosage Strength : 1%

Packaging : 5GX30

Approval Date :

Application Number : 2463806

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ACERUS BIOPHARMA INC

2024 ACI Convention

Not Confirmed

ACERUS BIOPHARMA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : NATESTO

Dosage Form : GEL

Dosage Strength : 4.5%/W/W

Packaging : 11G (60 ACTUATIONS)

Approval Date :

Application Number : 2450550

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : ANDROGEL

Dosage Form : GEL

Dosage Strength : 1%

Packaging : 30X2.5 G

Approval Date :

Application Number : 2245345

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : ANDROGEL

Dosage Form : GEL

Dosage Strength : 1%

Packaging : 30X 5 G

Approval Date :

Application Number : 2245346

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

BGP PHARMA ULC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : ANDROGEL

Dosage Form : GEL

Dosage Strength : 12.5MG/ACT

Packaging : 60 DOSES

Approval Date :

Application Number : 2249499

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ENDO OPERATIONS LTD.

Country

2024 ACI Convention

Not Confirmed

ENDO OPERATIONS LTD.

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

TESTOSTERONE

Brand Name : TESTIM 1%

Dosage Form : GEL

Dosage Strength : 1%

Packaging : 30X5G

Approval Date :

Application Number : 2280248

Regulatory Info : Schedule G (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?